Why Adbri, Costa, Delta Lithium, and Immutep shares are racing higher

These ASX shares are having a strong session despite the market volatility.

| More on:
A couple are shocked and elated at the good news they've just seen on their devices.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) has followed Wall Street's lead and dropped into the red. At the time of writing, the benchmark index is down 0.85% to 7,151.5.

Four ASX shares that are not letting that stop them from rising today are listed below. Here's why they are pushing higher:

Adbri Ltd (ASX: ABC)

The Adbri share price is up 12% to $1.80. This follows the release of a trading update at the building materials company's annual general meeting. Management advised that "underlying Net Profit After Tax for the period ending April 2023 is significantly above January to April 2022."

Costa Group Holdings Ltd (ASX: CGC)

The Costa share price is up 5% to $2.50. This also follows the release of a trading update at the horticulture company's annual general meeting. Management advised that "the 2023 International segment harvest is shaping up to be an exceptional year with very strong profit results emerging from both our China and Morocco operations."

Delta Lithium Ltd (ASX: DLI)

The Delta Lithium share price is up 2.5% to 67 cents. As mentioned here earlier this week, this lithium developer is rumoured to be a potential takeover target. In addition, despite rising strongly recently, Bell Potter still sees plenty of upside in its shares. It currently has a speculative buy rating and $1.05 price target on the ASX lithium share.

Immutep Ltd (ASX: IMM)

The Immutep share price is up 5.5% to 38 cents. This morning, this clinical-stage biotechnology company announced that the first patient has been enrolled and safely dosed at a European clinical site for its integrated Phase II/III AIPAC-003 trial in metastatic breast cancer.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Costa Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »